Controlled-release mitochondrial protonophore (CRMP) reverses dyslipidemia and hepatic steatosis in dysmetabolic nonhuman primates

MLA

Goedeke, Leigh, et al. “Controlled-Release Mitochondrial Protonophore (CRMP) Reverses Dyslipidemia and Hepatic Steatosis in Dysmetabolic Nonhuman Primates.” Science Translational Medicine, vol. 11, no. 512, Oct. 2019. EBSCOhost, https://doi.org/10.1126/scitranslmed.aay0284.

APA

Goedeke, L., Peng, L., Montalvo-Romeral, V., Butrico, G. M., Dufour, S., Zhang, X.-M., Perry, R. J., Cline, G. W., Kievit, P., Chng, K., Petersen, K. F., & Shulman, G. I. (2019). Controlled-release mitochondrial protonophore (CRMP) reverses dyslipidemia and hepatic steatosis in dysmetabolic nonhuman primates. Science Translational Medicine, 11(512). https://doi.org/10.1126/scitranslmed.aay0284

Chicago

Goedeke, Leigh, Liang Peng, Valle Montalvo-Romeral, Gina M. Butrico, Sylvie Dufour, Xian-Man Zhang, Rachel J. Perry, et al. 2019. “Controlled-Release Mitochondrial Protonophore (CRMP) Reverses Dyslipidemia and Hepatic Steatosis in Dysmetabolic Nonhuman Primates.” Science Translational Medicine 11 (512). doi:10.1126/scitranslmed.aay0284.